These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22027369)

  • 1. Monitored whole gene in vitro evolution of an anti-hRaf-1 affibody molecule towards increased binding affinity.
    Grimm S; Salahshour S; Nygren PÅ
    N Biotechnol; 2012 Jun; 29(5):534-42. PubMed ID: 22027369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and characterization of Affibody ligands to the transcription factor c-Jun.
    Lundberg E; Brismar H; Gräslund T
    Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):17-27. PubMed ID: 18260830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and characterisation of affibody molecules inhibiting the interaction between Ras and Raf in vitro.
    Grimm S; Lundberg E; Yu F; Shibasaki S; Vernet E; Skogs M; Nygren PÅ; Gräslund T
    N Biotechnol; 2010 Dec; 27(6):766-73. PubMed ID: 20674812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of an optimized scaffold for affibody molecules.
    Feldwisch J; Tolmachev V; Lendel C; Herne N; Sjöberg A; Larsson B; Rosik D; Lindqvist E; Fant G; Höidén-Guthenberg I; Galli J; Jonasson P; Abrahmsén L
    J Mol Biol; 2010 Apr; 398(2):232-47. PubMed ID: 20226194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand.
    Wållberg H; Löfdahl PK; Tschapalda K; Uhlén M; Tolmachev V; Nygren PK; Ståhl S
    Protein Expr Purif; 2011 Mar; 76(1):127-35. PubMed ID: 21029777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.
    Löfdahl PA; Nord O; Janzon L; Nygren PA
    N Biotechnol; 2009 Nov; 26(5):251-9. PubMed ID: 19576305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro.
    Jonsson A; Wållberg H; Herne N; Ståhl S; Frejd FY
    Biotechnol Appl Biochem; 2009 Aug; 54(2):93-103. PubMed ID: 19545237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.
    Grönwall C; Jonsson A; Lindström S; Gunneriusson E; Ståhl S; Herne N
    J Biotechnol; 2007 Jan; 128(1):162-83. PubMed ID: 17088007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotypic protein domains selected from protein A-based affibody libraries.
    Eklund M; Axelsson L; Uhlén M; Nygren PA
    Proteins; 2002 Aug; 48(3):454-62. PubMed ID: 12112671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry.
    Kronqvist N; Löfblom J; Jonsson A; Wernérus H; Ståhl S
    Protein Eng Des Sel; 2008 Apr; 21(4):247-55. PubMed ID: 18239074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for molecular recognition in an affibody:affibody complex.
    Lendel C; Dogan J; Härd T
    J Mol Biol; 2006 Jun; 359(5):1293-304. PubMed ID: 16750222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
    Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
    Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity binding to staphylococcal protein A by an engineered dimeric Affibody molecule.
    Lindborg M; Dubnovitsky A; Olesen K; Björkman T; Abrahmsén L; Feldwisch J; Härd T
    Protein Eng Des Sel; 2013 Oct; 26(10):635-44. PubMed ID: 23924760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
    Friedman M; Orlova A; Johansson E; Eriksson TL; Höidén-Guthenberg I; Tolmachev V; Nilsson FY; Ståhl S
    J Mol Biol; 2008 Mar; 376(5):1388-402. PubMed ID: 18207161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of a femtomolar affinity binding protein to human serum albumin.
    Jonsson A; Dogan J; Herne N; Abrahmsén L; Nygren PA
    Protein Eng Des Sel; 2008 Aug; 21(8):515-27. PubMed ID: 18499681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity maturation of a TNFalpha-binding affibody molecule by Darwinian survival selection.
    Löfdahl PA; Nygren PA
    Biotechnol Appl Biochem; 2010 Mar; 55(3):111-20. PubMed ID: 20121700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of folding and binding in an affibody:affibody complex.
    Dogan J; Lendel C; Härd T
    J Mol Biol; 2006 Jun; 359(5):1305-15. PubMed ID: 16701696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA mutagenesis yields highly diverse mRNA libraries for in vitro protein evolution.
    Kopsidas G; Carman RK; Stutt EL; Raicevic A; Roberts AS; Siomos MA; Dobric N; Pontes-Braz L; Coia G
    BMC Biotechnol; 2007 Apr; 7():18. PubMed ID: 17425805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity maturation of human growth hormone by monovalent phage display.
    Lowman HB; Wells JA
    J Mol Biol; 1993 Dec; 234(3):564-78. PubMed ID: 8254660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor β in vivo.
    Lindborg M; Cortez E; Höidén-Guthenberg I; Gunneriusson E; von Hage E; Syud F; Morrison M; Abrahmsén L; Herne N; Pietras K; Frejd FY
    J Mol Biol; 2011 Mar; 407(2):298-315. PubMed ID: 21277312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.